title: The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
abstract: Nucleotide excision repair (NER) is the only mechanism in humans to repair UV-induced DNA lesions such as pyrimidine (6-4) pyrimidone photoproducts and cyclobutane pyrimidine dimers (CPDs). In response to UV damage, the ataxia telangiectasia mutated and Rad3-related (ATR) kinase phosphorylates and activates several downstream effector proteins, such as p53 and XPA, to arrest cell cycle progression, stimulate DNA repair, or initiate apoptosis. However, following the completion of DNA repair, there must be active mechanisms that restore the cell to a prestressed homeostatic state. An important part of this recovery must include a process to reduce p53 and NER activity as well as to remove repair protein complexes from the DNA damage sites. Since activation of the damage response occurs in part through phosphorylation, phosphatases are obvious candidates as homeostatic regulators of the DNA damage and repair responses. Therefore, we investigated whether the serine/threonine wild-type p53-induced phosphatase 1 (WIP1/PPM1D) might regulate NER. WIP1 overexpression inhibits the kinetics of NER and CPD repair, whereas WIP1 depletion enhances NER kinetics and CPD repair. This NER suppression is dependent on WIP1 phosphatase activity, as phosphatase-dead WIP1 mutants failed to inhibit NER. Moreover, WIP1 suppresses the kinetics of UV-induced damage repair largely through effects on NER, as XPD-deficient cells are not further suppressed in repairing UV damage by overexpressed WIP1. Wip1 null mice quickly repair their CPD and undergo less UV-induced apoptosis than their wild-type counterparts. In vitro phosphatase assays identify XPA and XPC as two potential WIP1 targets in the NER pathway. Thus WIP1 may suppress NER kinetics by dephosphorylating and inactivating XPA and XPC and other NER proteins and regulators after UV-induced DNA damage is repaired.
authors.affiliation: Baylor College of Medicine, Houston, TX 77030, United States. thuyaitn@yahoo.com <thuyaitn@yahoo.com>
authors.forename: Thuy-Ai
authors.initials: TA
authors.lastname: Nguyen
authors.forename: Scott D
authors.initials: SD
authors.lastname: Slattery
authors.forename: Sung-Hwan
authors.initials: SH
authors.lastname: Moon
authors.forename: Yolanda F
authors.initials: YF
authors.lastname: Darlington
authors.forename: Xiongbin
authors.initials: X
authors.lastname: Lu
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Donehower
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004247:DNA / Q000235:genetics / Q000528:radiation effects; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000378:metabolism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009857:Oncogenes / Q000235:genetics / Q000502:physiology*; D010749:Phosphoprotein Phosphatases / Q000235:genetics / Q000502:physiology*; D000071636:Protein Phosphatase 2C; D014466:Ultraviolet Rays; D051760:Xeroderma Pigmentosum Group A Protein / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D051760:Xeroderma Pigmentosum Group A Protein; C501002:Xpc protein, mouse; D004247:DNA; C000607458:PPM1D protein, human; D010749:Phosphoprotein Phosphatases; C000607468:Ppm1d protein, mouse; D000071636:Protein Phosphatase 2C
references.citation: Oncogene. 2007 Feb 1;26(5):757-64
references.pmid: 16862173
references.citation: Biochemistry. 2005 Apr 12;44(14):5285-94
references.pmid: 15807522
references.citation: Science. 2007 May 25;316(5828):1160-6
references.pmid: 17525332
references.citation: Cancer Res. 2006 Feb 1;66(3):1391-400
references.pmid: 16452194
references.citation: Cancer Res. 2003 Apr 15;63(8):1876-83
references.pmid: 12702577
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2269-80
references.pmid: 19293255
references.citation: EMBO J. 2004 Dec 8;23(24):4835-46
references.pmid: 15549133
references.citation: Mol Cell. 2006 Sep 1;23(5):757-64
references.pmid: 16949371
references.citation: Curr Biol. 2005 Jan 26;15(2):105-15
references.pmid: 15668165
references.citation: J Biol Chem. 2009 Sep 4;284(36):24213-22
references.pmid: 19586908
references.citation: Cancer Metastasis Rev. 2008 Jun;27(2):123-35
references.pmid: 18265945
references.citation: Nat Genet. 2002 Jun;31(2):210-5
references.pmid: 12021785
references.citation: Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27
references.pmid: 18594563
references.citation: Nature. 2000 May 25;405(6785):473-7
references.pmid: 10839544
references.citation: Mol Cell. 2004 Aug 27;15(4):621-34
references.pmid: 15327777
references.citation: Nat Rev Cancer. 2001 Oct;1(1):22-33
references.pmid: 11900249
references.citation: Breast Cancer Res Treat. 2006 Feb;95(3):257-63
references.pmid: 16254685
references.citation: Cancer Res. 2006 Feb 1;66(3):1401-8
references.pmid: 16452195
references.citation: Oncogene. 2007 Mar 1;26(10):1449-58
references.pmid: 16936775
references.citation: DNA Repair (Amst). 2009 Sep 2;8(9):1055-67
references.pmid: 19497792
references.citation: Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6048-53
references.pmid: 9177166
references.citation: Cell Cycle. 2005 Aug;4(8):1060-4
references.pmid: 15970689
references.citation: Cell Mol Life Sci. 2009 Mar;66(6):994-1009
references.pmid: 19153657
references.citation: Cancer Res. 2006 Mar 15;66(6):2997-3005
references.pmid: 16540648
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17896-901
references.pmid: 19004803
references.citation: Nature. 2005 Apr 14;434(7035):864-70
references.pmid: 15829956
references.citation: Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):424-8
references.pmid: 9892649
references.citation: EMBO J. 2000 Dec 1;19(23):6517-26
references.pmid: 11101524
references.citation: Cancer Res. 2009 Oct 15;69(20):7960-8
references.pmid: 19808970
references.citation: DNA Repair (Amst). 2008 May 3;7(5):751-61
references.pmid: 18343205
references.citation: Cell Death Differ. 2006 Jul;13(7):1170-80
references.pmid: 16311512
references.citation: Nat Rev Cancer. 2003 Mar;3(3):155-68
references.pmid: 12612651
references.citation: J Cell Biochem. 2007 Mar 1;100(4):883-96
references.pmid: 17031865
references.citation: Mutagenesis. 2002 Mar;17(2):149-56
references.pmid: 11880544
references.citation: Mol Cell Biol. 2002 Feb;22(4):1094-105
references.pmid: 11809801
references.citation: Science. 2008 Mar 7;319(5868):1352-5
references.pmid: 18323444
references.citation: Mol Carcinog. 2006 Aug;45(8):594-604
references.pmid: 16652371
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12985-90
references.pmid: 12242345
references.citation: Nucleic Acids Res. 2002 May 1;30(9):1959-66
references.pmid: 11972333
references.citation: Methods Mol Biol. 2005;291:321-35
references.pmid: 15502233
references.citation: Nat Genet. 2002 Jun;31(2):133-4
references.pmid: 12021784
references.citation: Nature. 2001 May 17;411(6835):366-74
references.pmid: 11357144
references.citation: Clin Cancer Res. 2003 Jun;9(6):1995-2004
references.pmid: 12796361
references.citation: Chem Rev. 2006 Feb;106(2):253-76
references.pmid: 16464005
references.citation: EMBO J. 2002 Sep 2;21(17):4719-29
references.pmid: 12198174
references.citation: Cancer Cell. 2007 Oct;12(4):342-54
references.pmid: 17936559
references.citation: Nucleic Acids Res. 1996 Feb 1;24(3):433-40
references.pmid: 8602355
references.citation: Nature. 2005 Apr 14;434(7035):907-13
references.pmid: 15829965
references.citation: Genes Dev. 2005 May 15;19(10):1162-74
references.pmid: 15870257
references.citation: J Biol Chem. 2010 Apr 23;285(17):12935-47
references.pmid: 20118229